Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck & Co's Keytruda muscles further ahead of rivals in lung cancer

Merck & Co's Keytruda muscles further ahead of rivals in lung cancer reported last year, and approval alongside chemotherapy would lengthen Merck's lead over other PD-1/PD-L1 inhibitors. ... AstraZeneca's durvalumab and Merck KGaA/Pfizer's avelumab are currently vying to become the fourth market entrant, both for

FDA delays verdict on Roche's MS drug Ocrevus

FDA delays verdict on Roche's MS drug Ocrevus Ocrevus is the first investigational medicine with the potential to treat both forms, outperforming Merck KGaA's Rebif (interferon beta-1a) in the two relapsing multiple sclerosis phase III trials and

IFPMA elects Pfizer’s Ian Read as president

IFPMA elects Pfizer’s Ian Read as president Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term. ... The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) has elected Pfizer's Ian Read as its new president, succeeding Merck KGaA's Dr Stefan Oschmann.

QuintilesIMS launches European oncology data-gathering initiative

QuintilesIMS launches European oncology data-gathering initiative Will collaborate with Bristol-Myers Squibb, Lilly, Merck KGaA and Pfizer. QuintilesIMS has teamed up with four big pharma firms to gather insights into the real-world use of oncology therapies

FDA starts speedy review of Merck/Pfizer's PD-L1 inhibitor

FDA starts speedy review of Merck/Pfizer's PD-L1 inhibitor Pfizer and Merck KGaA have moved closer to bringing the fourth checkpoint inhibitor to the US market after the FDA granted a priority review for the drug in a rare form ... Merck and Pfizer also have phase II and III trials of avelumab ongoing in

[ Previous 5 results ] 21 22 23 24 25 26 27 28 29 30 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...